A 72-year-old man from Mumbai undergoes prostate biopsy for elevated PSA (18 ng/mL) and a hard nodule palpated in the right lobe on DRE. Histopathology shows malignant glands with loss of basal cell layer, nuclear enlargement, and prominent nucleoli. The pathologist assigns a Gleason score of 4 + 4 = 8. Immunohistochemistry shows loss of p63 and 34βE12 (basal cell markers). What is the most likely diagnosis and what does the Gleason score indicate?

Explanation

## Diagnosis: Adenocarcinoma of Prostate with High-Grade (Gleason 8) Disease ### Histopathological Diagnosis **Key Point:** The combination of: - Loss of basal cell layer (p63 and 34βE12 negative) - Nuclear enlargement and prominent nucleoli - Malignant glandular architecture ...is diagnostic of **adenocarcinoma of the prostate**. Loss of basal cells is the hallmark distinguishing invasive carcinoma from benign glands or PIN. ### Gleason Grading System **High-Yield:** Gleason score is the **gold standard prognostic tool** in prostate cancer. It grades glandular differentiation on a scale of 1–5 (1 = well-differentiated, 5 = undifferentiated). #### Gleason Score Interpretation | Gleason Score | Grade Group | Risk Category | 5-Year Progression Risk | Metastasis Risk | |---|---|---|---|---| | ≤6 | 1 | Very low | <5% | Minimal | | 3+4=7 | 2 | Low | 5–10% | Low | | 4+3=7 | 3 | Intermediate | 10–20% | Moderate | | 4+4=8 | 4 | **High** | 20–30% | **Significant** | | 4+5=9, 5+4=9, 5+5=10 | 5 | Very high | >30% | **Very high** | **Clinical Pearl:** Gleason 4+4=8 is classified as **Grade Group 4 (high-grade disease)**. This score indicates: - Poorly differentiated glands - Significant risk of extraprostatic extension - High metastatic potential - Poor prognosis without aggressive treatment ### Why Gleason 8 Is High-Grade, Not Intermediate **Mnemonic: GRADE GROUPS** — Remember that Grade Group 4 (Gleason 8) crosses the threshold from intermediate to high risk: - **Grade 1–2** (Gleason ≤7): Localized disease, good prognosis with treatment - **Grade 3** (Gleason 4+3=7): Intermediate, borderline - **Grade 4–5** (Gleason ≥8): High/very high grade, aggressive, metastatic potential ### Loss of Basal Cell Layer ```mermaid flowchart TD A[Normal prostate gland]:::outcome --> B[Intact basal cell layer<br/>p63 + 34βE12 positive] B --> C[Benign epithelium] D[Adenocarcinoma]:::outcome --> E[Loss of basal cell layer<br/>p63 + 34βE12 negative] E --> F[Invasive malignant cells] G[PIN]:::outcome --> H[Intact basal cell layer<br/>p63 + 34βE12 positive] H --> I[Precancerous, confined within ducts] ``` **Key Point:** Immunohistochemical loss of basal cell markers (p63, 34βE12) is the **definitive marker of invasion**. This distinguishes adenocarcinoma from PIN (which retains basal cells) and benign hyperplasia. ### Clinical Implications of Gleason 8 - **Treatment:** Requires aggressive multimodal therapy (radical prostatectomy ± radiation ± androgen deprivation therapy) - **Staging:** Necessitates full staging workup (bone scan, CT/MRI) to exclude metastases - **Prognosis:** 5-year biochemical recurrence risk ~30–40% even with treatment - **Surveillance:** Close PSA monitoring and imaging follow-up mandatory